Abstract
A sensitive and reliable high-pressure liquid chromatography (HPLC) assay for miloxacin and its two principal metabolites, 5,8-dihydro-8-oxo-2H-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid (M-1) and 1,4-dihydro-1,6-dimethoxy-7-hydroxy-4-oxoquinoline-3-carboxylic acid (M-2), in human serum and urine was developed. A strong anion-exchange Zipax SAX column using a mobile phase of 0.01 M citric acid solution containing 0.03 M sodium nitrate with pH 5.0 was used to achieve separation of the three compounds. The retention times of miloxacin, M-1, and M-2 were 3.8, 9.3, and 5.9 min, respectively. Serum and urine concentrations of these compounds as low as 10 ng/ml were measured. When results from the HPLC assay were compared with those from the microbiological assay of serum and urine samples from human subjects receiving miloxacin orally, the correlation coefficients were 0.94 for the serum and 0.99 for the urine. The HPLC assay method presents an alternative to the microbiological assay and permits future pharmacokinetic investigations of miloxacin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agui H., Mitani T., Izawa A., Komatsu T., Nakagome T. Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. J Med Chem. 1977 Jun;20(6):791–796. doi: 10.1021/jm00216a010. [DOI] [PubMed] [Google Scholar]
- Yoshitake A., Kawahara K., Shono F. [Metabolism of 14C-miloxacin in rats--metabolites in urine, bile and feces (author's transl)]. Radioisotopes. 1979 Nov;28(11):687–691. doi: 10.3769/radioisotopes.28.11_687. [DOI] [PubMed] [Google Scholar]